CeNeRx

Cerevance

This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.

Cyclerion Therapeutics

This biopharmaceutical company develops neuropsychiatric therapies for patients with treatment-resistant depression and other neurodegenerative diseases.

Cerevel Therapeutics

This biopharmaceutical company develops neuroscience medicines for patients with mental and neurological conditions including schizophrenia, Parkinson's disease and epilepsy.

Cyclera Therapeutics

This company develops catalytic protein degradation therapeutics to treat neuropsychiatric, neurodegenerative and cancer disorders for patients with central nervous system diseases.

Neuro3D SA

This company develops pharmaceutical treatments for central nervous system disorders such as schizophrenia and depression for the healthcare and medical research sectors.

BrainCells (BCI)

This biopharmaceutical company develops neurogenic compounds to treat central nervous system diseases for patients with psychiatric and neurological disorders.

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

Saol Therapeutics

This pharmaceutical company develops clinical-stage therapies for patients with central nervous system disorders, pain, spasticity and orphan diseases.